Cognitive Behavioral Therapy for Depression in Parkinson's Disease

Sponsor
Oregon Health and Science University (Other)
Overall Status
Terminated
CT.gov ID
NCT00810628
Collaborator
National Parkinson Foundation (Other)
12
1
1
11
1.1

Study Details

Study Description

Brief Summary

The purpose of this pilot program is to develop and evaluate a new treatment program for depression in Parkinson's disease (PD). The treatment uses Cognitive Behavior Therapy(CBT)to teach patients how to become more aware of their thoughts and feelings and to change thinking patterns and behaviors that may be related to depressive symptoms. This is the first time that this treatment has been used in a group setting for depression in PD.

Target population is patients in the Movement Disorders Clinic at Oregon Health & Science University who have Parkinson's disease and mild to moderate depression.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Cognitive Behavioral Therapy
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
12 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Supportive Care
Official Title:
Depression in Parkinson's Disease: A Pilot Project Using Cognitive Behavioral Therapy (CBT) to Improve Depression and Coping
Study Start Date :
Jan 1, 2009
Actual Primary Completion Date :
Sep 1, 2009
Actual Study Completion Date :
Dec 1, 2009

Arms and Interventions

Arm Intervention/Treatment
Experimental: 1

All subjects in same investigative group with same CBT intervention.

Behavioral: Cognitive Behavioral Therapy
Individual interviews and group discussion/training.

Outcome Measures

Primary Outcome Measures

  1. The change in CESD score [Baseline and 10 weeks]

Eligibility Criteria

Criteria

Ages Eligible for Study:
35 Years to 85 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Parkinson's disease, mild to moderate depression, seen at Oregon Health & Science University
Exclusion Criteria:
  • Suicidal

  • Cognitive impairment with MOCA <26

Contacts and Locations

Locations

Site City State Country Postal Code
1 Oregon Health & Science University Portland Oregon United States 97239

Sponsors and Collaborators

  • Oregon Health and Science University
  • National Parkinson Foundation

Investigators

  • Principal Investigator: Julie H. Carter, MS, Oregon Health and Science University
  • Principal Investigator: Kristine Hanna, PhD, Oregon Health and Science University

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
, ,
ClinicalTrials.gov Identifier:
NCT00810628
Other Study ID Numbers:
  • OHSUIRB4613
First Posted:
Dec 18, 2008
Last Update Posted:
Oct 24, 2014
Last Verified:
Dec 1, 2008

Study Results

No Results Posted as of Oct 24, 2014